NCT04431141View on ClinicalTrials.gov

Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 15, 2020

Primary Completion Date

November 16, 2020

Study Completion Date

January 25, 2021

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Teneligliptin

Teneligliptin alone

DRUG

Empagliflozin

Empagliflozin alone

DRUG

Teneligliptin and Empagliflozin

Teneligliptin and empagliflozin

Trial Locations (1)

Unknown

Clinical Pharmacology, Asan Medical Center, Seoul

Sponsors

Lead Sponsor

Handok Inc.
All Listed Sponsors
lead

Handok Inc.

INDUSTRY